These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2834287

  • 21. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
    Catalano MA, Carson DA, Niederman JC, Feorino P, Vaughan JH.
    J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
    [Abstract] [Full Text] [Related]

  • 22. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 23. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E, Tsoukas CD, Vaughan JH, Altman A, Carson DA.
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [Abstract] [Full Text] [Related]

  • 24. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test.
    Burgio GR, Monafo V.
    Infection; 1983 Jan; 11(1):1-5. PubMed ID: 6302006
    [Abstract] [Full Text] [Related]

  • 25. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E, Masucci MG.
    Springer Semin Immunopathol; 1982 Jan; 5(1):63-73. PubMed ID: 6314570
    [No Abstract] [Full Text] [Related]

  • 26. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 27. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P, Ernberg I, Klein G, Steinitz M.
    Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
    [Abstract] [Full Text] [Related]

  • 28. The changing faces of EBV research.
    Klein G, Klein E.
    Prog Med Virol; 1984 Dec; 30():87-106. PubMed ID: 6087416
    [No Abstract] [Full Text] [Related]

  • 29. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M.
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [Abstract] [Full Text] [Related]

  • 30. Phorbol ester-induced expression and function of the interleukin 2 receptor in human B lymphocytes.
    Ando I, Crawford DH, Kissonerghis MA, Owen MJ, Beverley PC.
    Eur J Immunol; 1985 Apr; 15(4):341-4. PubMed ID: 2985401
    [Abstract] [Full Text] [Related]

  • 31. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC, Dorval G, Menezes J.
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [Abstract] [Full Text] [Related]

  • 32. Tac expression induced by Epstein-Barr virus is restricted on non-transformable B lymphocytes.
    Gosselin J, Desrosiers M, Mercier G, Menezes J, Lamoureux G, Oth D.
    Immunol Lett; 1988 May; 18(1):9-13. PubMed ID: 2837437
    [Abstract] [Full Text] [Related]

  • 33. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 34. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P, Zhang XM, Ohlin M, Zeuthen J, Borrebaeck CA.
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [Abstract] [Full Text] [Related]

  • 35. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET, Lareau M, Rosenwasser LJ, Dinarello CA, Geha RS.
    J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
    [Abstract] [Full Text] [Related]

  • 36. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV, Keightley RG.
    Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA.
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-2 promoter activity in Epstein-Barr virus-transformed B lymphocytes is controlled by nuclear factor-chi B.
    Mouzaki A, Serfling E, Zubler RH.
    Eur J Immunol; 1995 Aug; 25(8):2177-82. PubMed ID: 7664781
    [Abstract] [Full Text] [Related]

  • 39. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Thorley-Lawson DA, Schooley RT, Bhan AK, Nadler LM.
    Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.